Niagen Bioscience Inc. logo

Niagen Bioscience Inc. (NAGE)

Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM)
$
2. 49
-0.09
-3.4884%
$
- Market Cap
- P/E Ratio
- Div Yield
555,766 Volume
- Eps
$ 2.58
Previous Close
Add Transaction
Day Range
2.48 2.59
Year Range
2.46 7.95
Want to track NAGE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

NAGE closed today lower at $2.49, a decrease of -3.4884% from yesterday's close, completing a monthly decrease of -14.433% or -$0.42. Over the past 12 months, NAGE stock lost -61.0937%.
NAGE is not paying dividends to its shareholders.
The last earnings report, released on May 13, 2026, missed the consensus estimates by -0.0533%. On average, the company has fell short of earnings expectations by -0.0159%, based on the last three reports.
Niagen Bioscience Inc. has completed 1 stock splits, with the recent split occurring on Apr 13, 2016.
The company's stock is traded on one exchange.

NAGE Chart

Niagen Bioscience, Inc. (NAGE) Q2 2026 Earnings Call Transcript

Niagen Bioscience, Inc. (NAGE) Q2 2026 Earnings Call Transcript

Niagen Bioscience, Inc. (NAGE) Q2 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
Niagen Bioscience (NAGE) Meets Q2 Earnings Estimates

Niagen Bioscience (NAGE) Meets Q2 Earnings Estimates

Niagen Bioscience (NAGE) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.04 per share a year ago.

Zacks | 2 months ago
Niagen Bioscience, Inc. (NAGE) Discusses Strategic Expansion Into Pharmaceutical Development and NB4168 Drug Program Transcript

Niagen Bioscience, Inc. (NAGE) Discusses Strategic Expansion Into Pharmaceutical Development and NB4168 Drug Program Transcript

Niagen Bioscience, Inc. (NAGE) Discusses Strategic Expansion Into Pharmaceutical Development and NB4168 Drug Program Transcript

Seekingalpha | 3 months ago

Niagen Bioscience Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Curtis Ellergodt
Curtis Ellergodt Rothschild Investment LLC
725 $3,344.91 $1,834.25 -$1,510.66 -45.16%
JD
Jim Dushek HARBOUR INVESTMENTS Inc.
800 $2,640 $2,024 -$616 -23.33%
BG
Bart Gancher Intech Investment Management LLC
14,463 $173,337.56 $37,314.54 -$136,023.02 -78.47%
KAC
Kimberly A. Clarke Stoneridge Investment Partners LLC
14,477 $92,051.78 $37,278.27 -$54,773.51 -59.5%
CD
Charlie Durham Sterling Capital Management LLC
203 $1,291.06 $513.59 -$777.47 -60.22%

Niagen Bioscience Inc. (NAGE) FAQ

What is the stock price today?

The current price is $2.49.

On which exchange is it traded?

Niagen Bioscience Inc. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is NAGE.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Niagen Bioscience Inc. ever had a stock split?

Niagen Bioscience Inc. had 1 splits and the recent split was on Apr 13, 2016.